Gallium (68Ga), Pentixafor — Drug Intelligence | 8 EU Trials

Filter these 8 trials by condition, phase, country and more.

Open in Search →

8 Registered trials

4 Recruiting

2 Completed trials

7 Sponsors

7 Countries

Phase III

Phase II/III

Phase II

Phase I/II

Phase I (Other)

Phase III: 1 Phase II/III: 2 Phase II: 1 Phase I/II: 3 Phase I (Other): 1

Indications tested

Primary hyperaldosteronism 2 Cardiac sarcoidosis 1 Non-Hodgkin's lymphoma 1 Neoplasm malignant 1 Marginal zone lymphoma 1

Sponsors using this IMP

Pentixapharm AG 2 Assistance Publique Hopitaux De Paris 1 Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) 1 Institut De Cancerologie De L Ouest 1 Klinikum rechts der Isar der TU Muenchen AöR 1 Radboud universitair medisch centrum Stichting 1 University Of Antwerp 1

All trials

8 total

CHEMOKINE RECEPTOR CXCR4-DIRECTED THERANOSTICS OF ADVANCED LYMPHOPROLIFERATIVE CANCERS BY RADIOPEPTIDE-BASED IMAGING AND THERAPY: THE COLPRI… Pending

2024-517639-35-00 Phase I/II 1 country Klinikum rechts der Isar der TU Muenchen AöR
New PET/CT for (possible) cardiac sarcoidosis Pending

2025-523646-27-00 Phase II 1 country Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
ProspectivE phase 0 pilot study, assessing potential prognostic and theranostic interest of 68Ga-PentiXafor PET-CT In metastatic triple neGa… Recruiting

2024-517658-90-00 Phase I (Other) 1 country Institut De Cancerologie De L Ouest
CXCR4-directed [68Ga]Ga-PentixaFor PET/CT vs AVS performance in a diagnoStic randomized Trial Ultimately comparing hypertenSion outcome in p… Recruiting

2024-512628-12-00 Phase II/III 1 country Stichting Radboud universitair medisch centrum
[68Ga]Ga-PentixaFor positron emission tomography for improved risk and disease assessment in myeloma Recruiting

2022-501811-14-00 Phase I/II 2 countries University Of Antwerp
A study to examine the safety, tolerablity, body distribution and efficacy of [90Y]Y-PentixaTher therapy in CNS lymphoma patients. Recruiting

2024-512097-98-00 Phase I/II 1 country Pentixapharm AG
Pilot study for the evaluation of [68Ga]Ga-PentixaFor PET imaging for the identification of unilateral adrenal secretion of ALdosterON in pa… Ended

2023-505507-22-00 Phase II/III 1 country Assistance Publique Hopitaux De Paris
[68Ga]Ga-PentixaFor-PET imaging for staging of marginal zone lymphoma Ended

2022-500918-25-00 Phase III 5 countries Pentixapharm AG

Showing 1–8 of 8 trials

← All drugs A–Z